AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport

Targeted Isotretinoin in Neuroblastoma: Kinetics, Genetics, or Absorption

(2012) K. K. Matthay   CLINICAL CANCER RESEARCH

Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma

(2012) Laura D. Gamble et al.   Frontiers in Oncology

Neuroblastoma: Biology, Prognosis, and Treatment

(2010) Julie R. Park et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Targeting Ornithine Decarboxylase Impairs Development of MYCN-Amplified Neuroblastoma

(2009) R. J. Rounbehler et al.   CANCER RESEARCH

Lipophilic Lysine−Spermine Conjugates Are Potent Polyamine Transport Inhibitors for Use in Combination with a Polyamine Biosynthesis Inhibitor

(2009) Mark R. Burns et al.   JOURNAL OF MEDICINAL CHEMISTRY

Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial

(2008) Frank L. Meyskens et al.   Cancer Prevention Research

Ornithine Decarboxylase Inhibition by  -Difluoromethylornithine Activates Opposing Signaling Pathways via Phosphorylation of Both Akt/Protein Kinase B and p27Kip1 in Neuroblastoma

(2008) D.-L. T. Koomoa et al.   CANCER RESEARCH